ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

RHEUMATOLOGICAL MANIFESTATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

AUTHORS:

Dr Muhammad Aslam Rind, Dr. Maria Nazir, Dr Muhammad Saleem Rind

ABSTRACT:

OBJECTIVE:to explore the rheumatological manifestations in patients with type 2 diabetes mellitus. PATIENTS AND METHODS: The six month cross sectional study explored the diabetic population either gender for the rheumatological disorders. The detailed history and clinical examination was performed while along the baseline investigations the specific investigations were advised. The frequency / percentages (%) and means ±SD computed for study variables. RESULTS:During six months study period total fifty patients with type 2 diabetes mellitus were explored and studied. The frequency for male and female population was 30 (60%) and 20 (40%) with mean ± SD for age of male and female individuals was 50.93±8.97 and 52.51±5.85 respectively.Regarding gender distribution male 30 (60%) and female 20 (40%), duration of diabetes mellitus (yrs) less than five years 08 (16%), five to ten years 30 (60%) and more than ten years 12 (24%). The glycemic status controlled 20 (40%) and un-controlled 30 (60%). Regarding the treatment on insulin 14 (28%), on OHA 15 (30%) and on insulin + oha 21 (42%) while the rheumatological manifestation was observed in 35 (70%) whereas the co-morbidity hypertension 22 (44%), dyslipidemia 15 (30%) and obesity 13 (26%). Regarding the rheumatological manifestations frozen shoulder 07 (20%), diffuse idiopathic skeletal hyperostosis (DISH) 06 (17%), carpal tunnel syndrome 06 (17%), osteoarthritis 08 (22.8%), charcot joint 03 (8.5%), dipyrrin’s contracture 01 (2.8%) andcheiroarthropathy 04 (11.4%). CONCLUSION:The prevalence of rheumatological manifestations is greater in patients with type 2 diabetes mellitus. KEYWORDS:Rheumatology, Diabetes Mellitus and Joint disorders

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.